Tag: cannabis stock

Last week, three prominent cannabis companies—Cronos Group (CRON), Aurora Cannabis (ACB), and Canopy Growth (CGC)(WEED)—reported earnings results.

In the November 14 trading session, Aurora Cannabis (ACB) stock fell 12.7% from the previous session during after-hours trading.

Today, Canopy Growth (CGC) (WEED) reported its earnings for the second quarter of fiscal 2020, which ended on September 30.

On November 12, the cannabis sector was in the red despite the broader US equity market trading in positive territory. Here's why.

Aurora Cannabis stock (ACB) has definitely not lived up to investors' expectations in 2019. The stock is down 30.61% to 4.92 Canadian dollars on the TSE.

Aphria’s stock price has risen 8.9% since reporting its Q1 earnings on October 15. The cannabis sector's weakness offset some of these gains.

Innovative Industrial Properties (IIPR) is scheduled to release its Q3 earnings results on November 6. Find out what cannabis investors can expect.

To provide information on safely storing cannabis-infused edibles, Aurora Cannabis has launched a national safety campaign in Canada.

Canada-based diversified cannabis and hemp company Canopy Growth is set to report its fiscal 2020 second-quarter results on November 14.

On October 25, Aurora Cannabis said that a research study showed that its CanniMed 1:20 oil could lower or cure seizures in young patients with severe epilepsy.